1. Home
  2. ACR vs VTVT Comparison

ACR vs VTVT Comparison

Compare ACR & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$23.76

Market Cap

143.3M

Sector

Real Estate

ML Signal

HOLD

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

HOLD

Current Price

$35.69

Market Cap

127.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACR
VTVT
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.3M
127.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ACR
VTVT
Price
$23.76
$35.69
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$24.50
$37.00
AVG Volume (30 Days)
50.5K
12.6K
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
14.65
N/A
EPS
0.95
N/A
Revenue
$88,952,000.00
$17,000.00
Revenue This Year
$4.05
N/A
Revenue Next Year
$0.38
N/A
P/E Ratio
$24.86
N/A
Revenue Growth
14.87
N/A
52 Week Low
$14.94
$13.15
52 Week High
$24.17
$35.95

Technical Indicators

Market Signals
Indicator
ACR
VTVT
Relative Strength Index (RSI) 68.90 72.05
Support Level $22.74 $32.84
Resistance Level $23.99 $35.95
Average True Range (ATR) 0.90 2.17
MACD 0.19 0.67
Stochastic Oscillator 89.43 97.41

Price Performance

Historical Comparison
ACR
VTVT

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.

Share on Social Networks: